Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fresh Day Meds vs NativeMed

Fresh Day Meds
Graded #20

Higher grade

vs+21.6
NativeMed
Graded #292

Lower grade

The verdict

Fresh Day Meds takes it — 84.3/100 to 62.7/100.

Fresh Day Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tight both-molecule spread ($133/$166), verified and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFresh Day Meds +14
88
74
Dose & formulationFresh Day Meds +16
80
64
Clinical oversightFresh Day Meds +29
84
55
Labs & monitoringFresh Day Meds +29
82
53
FulfillmentFresh Day Meds +20
87
67
Contract termsFresh Day Meds +30
85
55
Fresh Day Meds · left barNativeMed · right bar

The numbers

MetricFresh Day MedsNativeMed
WeighScore84.3/10062.7/100
GradeBC
Scorecard rank#20#292
Semaglutide$133/mo$149/mo (promotional rate, compounded)
Tirzepatide$166/mo$183/mo (promotional rate, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Fresh Day Meds

Graded #20 · B

Strengths

  • $133 sema / $166 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Monitoring detail not published
  • Newer brand
NativeMed

Graded #292 · C

FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

Where it loses points

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
  • FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard